Careers | Find us | Contact us
2026-02-23T11:21:13+00:0024 February 2026|
Step inside the world of Professor Jukka Corander, Associate Faculty at the Wellcome Sanger Institute. From exploring the wonders of nature to investigating the tiny organisms that inhabit it, Jukka is guided by an insatiable curiosity.
2025-10-29T10:02:28+00:001 October 2025|
Our scientists and collaborators are working together to tackle one of the biggest public health threats: antimicrobial resistance. We are using cutting-edge genomics to hunt down drug-resistant microbes, decode their secrets and stop them in their tracks.
2025-06-02T10:18:01+01:0027 May 2025|
With the World Health Organization (WHO) recently adopting an agreement on pandemic preparedness, we spoke with John Sillitoe, Director of the Sanger Institute’s Genomic Surveillance Unit, to find out more about the role data and genomics can play in preventing future outbreaks.
2025-05-06T12:41:28+01:006 May 2025|
We spoke to Dr Trevor Lawley, Senior Group Leader at the Wellcome Sanger Institute who works in the Parasites and Microbes Programme. Trevor’s is the story of turning basic, fundamental research into innovative science with potential to treat a broad range of human diseases.
2025-03-21T15:27:49+00:0021 March 2025|
For 25 years, Nick Thomson has used genomics to unlock the secrets of how infectious diseases spread around the world. We sat down with Nick to discover his plans as the new Head of the Parasites and Microbes programme.
2025-01-16T14:21:41+00:001 December 2024|
Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.
2024-11-07T12:48:04+00:0031 October 2024|
Arnav Lal is interested in merging clinical practice with infectious disease research. He has recently completed his year-long Master’s in Biological Science through the Churchill Scholarship, provided by the University of Cambridge. For his Master’s he conducted research at the Wellcome Sanger Institute on antimicrobial resistance and used genomics to study how bacteria pass mobile genetic elements around. We caught up with him to talk about his experiences before he moved on to his next step, beginning his studies at Harvard medical school.
2024-09-06T10:23:10+01:006 September 2024|
Did you know that your gut bugs may affect your cancer risk? Dr Ashray Gunjur, Clinical Research Training Fellow at the Wellcome Sanger Institute, is exploring how clinicians can use the biology of the gut microbiome to personalise cancer treatment.
2024-07-19T15:01:44+01:0017 July 2024|
Dedicating his career to decoding the genomics of disease-causing bacteria, Stephen Bentley has innovatively applied emerging technologies.
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244
